Terms: = Head and neck cancer AND ELK4, SAP1, 2005, ENSG00000158711, P28324
3438 results:
1. The Clinical Impact of the Pretreatment Albumin to Fibrinogen Ratio in Esophageal cancer Patients Who Receive Curative Treatment.
Aoyama T; Maezawa Y; Hashimoto I; Hara K; Kazama K; Komori K; Kato A; Otani K; Tamagawa A; Cho H; Morita J; Kawahara S; Tanabe M; Oshima T; Saito A; Yukawa N; Rino Y
In Vivo; 2024; 38(3):1253-1259. PubMed ID: 38688590
[TBL] [Abstract] [Full Text] [Related]
2. Occupation and tongue cancer in Nordic countries.
Peltonen J; Nikkilä R; Al-Samadi A; Mäkitie A; Martinsen JI; Kjaerheim K; Lynge E; Sparen P; Tryggvadottir L; Weiderpass E; Salo T; Pukkala E
BMC Oral Health; 2024 Apr; 24(1):506. PubMed ID: 38685000
[TBL] [Abstract] [Full Text] [Related]
3. The Prognostic Immune and Nutritional Indices Are Independent Prognostic Factors for Esophageal cancer Patients Who Receive Curative Treatment.
Aoyama T; Hashimoto I; Maezawa Y; Hara K; Kato A; Kazama K; Tamagawa A; Cho H; Nakazono M; Numata M; Kawahara S; Oshima T; Saito A; Yukawa N
Anticancer Res; 2024 May; 44(5):2185-2192. PubMed ID: 38677744
[TBL] [Abstract] [Full Text] [Related]
4. Depth of invasion as an independent prognostic factor in early-stage oral cavity squamous cell carcinoma.
Koh ES; Pandey A; Banuchi VE; Kuhel WI; Tassler A; Scognamiglio T; Kutler DI
Am J Otolaryngol; 2024; 45(3):104269. PubMed ID: 38522260
[TBL] [Abstract] [Full Text] [Related]
5. Deletion of concurrent chemotherapy on the basis of sequential chemoradiotherapy for non-metastatic stage T4 nasopharyngeal carcinoma in IMRT era.
Zheng Y; Xue F; Ou D; Niu X; Hu C; He X
Cancer Med; 2024 Feb; 13(4):e6578. PubMed ID: 38457191
[TBL] [Abstract] [Full Text] [Related]
6. Somatic CDKN2A copy number variations are associated with the prognosis of esophageal squamous cell dysplasia.
Fan Z; Zhou J; Tian Y; Qin Y; Liu Z; Gu L; Dawsey SM; Wei W; Deng D
Chin Med J (Engl); 2024 Apr; 137(8):980-989. PubMed ID: 38445358
[TBL] [Abstract] [Full Text] [Related]
7. Primary thyroid lymphoma: a case series.
Sakhri S; Zemni I; Ayadi MA; Kamoun S; Chargui R; Ben Dhiab T
J Med Case Rep; 2024 Feb; 18(1):108. PubMed ID: 38395921
[TBL] [Abstract] [Full Text] [Related]
8. Sellar Reconstruction With a Bioabsorbable Plate After Endoscopic Transsphenoidal Pituitary Adenoma Resection: Safe and Efficacious.
Thorpe RK; Dougherty MC; Walsh JE; Graham SM; Greenlee JDW
Ann Otol Rhinol Laryngol; 2024 May; 133(5):490-494. PubMed ID: 38372259
[TBL] [Abstract] [Full Text] [Related]
9. Mucosal melanoma of the head and neck: a retrospective analysis of 34 cases in Japan.
Tamura K; Kumabe Y; Kishimoto Y; Kitamura M; Mizuta M; Tamaki H; Honda K; Yamada K; Tanaka S; Kojima T; Asato R; Ushiro K; Shinohara S; Takebayashi S; Maetani T; Ichimaru K; Kitani Y; Omori K
Acta Otolaryngol; 2024 Jan; 144(1):82-89. PubMed ID: 38362716
[TBL] [Abstract] [Full Text] [Related]
10. Stroke Risk in Survivors of head and neck cancer.
Yip PL; Zheng H; Cheo T; Tan TH; Lee SF; Leong YH; Wong LC; Tey J; Ho F; Soon YY
JAMA Netw Open; 2024 Feb; 7(2):e2354947. PubMed ID: 38349657
[TBL] [Abstract] [Full Text] [Related]
11. Impact of extra-nodal extension and AJCC lymph node staging in predicting recurrence following lymphadenectomy in patients with melanoma.
Downey J; Hamm J; Baliski C
Am J Surg; 2024 May; 231():120-124. PubMed ID: 38320886
[TBL] [Abstract] [Full Text] [Related]
12. Prognostic value of pretreatment inflammatory biomarkers in patients with laryngeal cancer.
Kawano T; Hirano T; Tateyama K; Yoshinaga K; Shinomura K; Suzuki M
Asian J Surg; 2024 May; 47(5):2144-2151. PubMed ID: 38311505
[TBL] [Abstract] [Full Text] [Related]
13. CRP-albumin-lymphocyte (CALLY) Index Is an Independent Prognostic Factor for the Esophageal cancer Patients Who Received Curative Treatment.
Aoyama T; Hashimoto I; Maezawa Y; Hara K; Kazama K; Komori K; Numata M; Tamagawa A; Fukuda M; Cho H; Morita J; Yoshizawa S; Otani K; Kato A; Tanabe M; Nakazono M; Kawahara S; Oshima T; Saito A; Yukawa N; Rino Y
Anticancer Res; 2024 Feb; 44(2):815-822. PubMed ID: 38307573
[TBL] [Abstract] [Full Text] [Related]
14. Clinical Impact of Conversion Surgery After Induction Therapy for Esophageal cancer with Synchronous Distant Metastasis: A Multi-institutional Retrospective Study.
Sugimura K; Tanaka K; Sugase T; Momose K; Kanemura T; Yamashita K; Makino T; Shiraishi O; Motoori M; Yamasaki M; Miyata H; Fujitani K; Yasuda T; Yano M; Eguchi H; Doki Y
Ann Surg Oncol; 2024 May; 31(5):3437-3447. PubMed ID: 38300405
[TBL] [Abstract] [Full Text] [Related]
15. The cancer Survivorship Program at the Abramson cancer Center of the University of Pennsylvania.
Jacobs LA
J Cancer Surviv; 2024 Feb; 18(1):29-33. PubMed ID: 38294601
[TBL] [Abstract] [Full Text] [Related]
16. Induction chemotherapy followed by response evaluation and esophagectomy for advanced esophageal cancer.
van der Zijden CJ; van der Sluis PC; Mostert B; Nuyttens JJME; Spaander MCW; Toxopeus ELA; Valkema R; Beerepoot LV; van Halteren HK; Lagarde SM; Wijnhoven BPL
Eur J Surg Oncol; 2024 Mar; 50(3):107968. PubMed ID: 38241878
[TBL] [Abstract] [Full Text] [Related]
17. Loss in life expectancy in patients with stage II-III cutaneous melanoma in Sweden: A population-based cohort study.
Vikström S; Syriopoulou E; Andersson TM; Eriksson H
J Am Acad Dermatol; 2024 May; 90(5):963-969. PubMed ID: 38218560
[TBL] [Abstract] [Full Text] [Related]
18. Lymphocyte to Monocyte Ratio Is an Independent Prognostic Factor in Patients With Esophageal cancer Who Receive Curative Treatment.
Aoyama T; Kato A; Maezawa Y; Hashimoto I; Hara K; Komori K; Kawahara S; Numata M; Kazama K; Sawazaki S; Kamiya N; Yoshizawa S; Otani K; Tamagawa A; Cho H; Tamagawa H; Oshima T; Yukawa N; Saito A; Rino Y
Anticancer Res; 2024 Jan; 44(1):339-346. PubMed ID: 38159996
[TBL] [Abstract] [Full Text] [Related]
19. Pretreatment Fibrinogen Level Is a Prognostic Factor for Esophageal cancer Patients Who Receive Curative Treatment.
Aoyama T; Kato A; Hashimoto I; Maezawa Y; Hara K; Kawahara S; Kazama K; Komori K; Yoshizawa S; Tamagawa A; Tateishi M; Minami T; Cho H; Morita J; Otani K; Sawazaki S; Numata M; Tanabe M; Oshima T; Saito A; Yukawa N; Rino Y
Anticancer Res; 2024 Jan; 44(1):249-255. PubMed ID: 38159985
[TBL] [Abstract] [Full Text] [Related]
20. Tumor volume-doubling rate is negatively associated with patient age in papillary thyroid microcarcinomas under active surveillance.
Yamamoto M; Miyauchi A; Ito Y; Fujishima M; Sasaki T; Kudo T
Surgery; 2024 Apr; 175(4):1089-1094. PubMed ID: 38142143
[TBL] [Abstract] [Full Text] [Related]
[Next]
